Efficacy Preclinical Studies Conducted by UTRF, UTHSC, and Veru Inc.’s University-Industry Partnership Memphis, Tennessee: A research collaboration between the University of Tennessee Health Science Center (UTHSC), the University of Tennessee Research Foundation (UTRF), and biopharmaceutical company Veru Inc. has resulted in a promising next generation oral cancer therapy, VERU-111, which has the potential to treat (read more)
UTRF in the News
Electro-Active Technologies licenses biorefinery innovations jointly patented by ORNL and UTRF
Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel. The system combines biology and electrochemistry (read more)
UTRF Takes UT Prototype to Market to Help Hospitals Cut Costs on IV Drug Use
The story of the TEL BOXX: a partnership between UT and UTRF to address a relevant need, prepare a product for market, and create positive impact. As hospitals across the country see an increase in patients addicted to heroin and other injectable opioids, they’re also facing new treatment challenges: patients with a history of intravenous (read more)